Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novo Nordisk Foundation Cellerator P/S
KAS
Active
CVR 44450569
Nordvej 250A, 2800
Kongens Lyngby
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023 · 2 years old
33 employees
www.cellerator.dk
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Novo Nordisk Foundation Cellerator P/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
5M
-11M
2024
4M
2025
EBITDA
DKK millions
0M
-4M
-8M
-12M
-16M
-11M
2024
-13M
-18%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
-10.780
3.903
Staff expenses
-0
-16.865
EBITDA
-10.780
-12.962
Depreciation & amort.
-0
-0
EBIT
-10.780
-12.962
Net financials
1.503
-92
Profit before tax
-9.277
-13.054
Tax
-0
-0
Net profit
-9.277
-13.054
Balance sheet
DKK thousands
Item
2024
2025
Total assets
241.884
392.344
Equity
200.514
346.460
Long-term debt
0
0
Short-term debt
41.370
45.884
Total debt
41.370
45.884
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-332.1%
This company
2024
2025
Equity ratio
88.3%
This company
38.2%
Market median
+131% vs market
2024
2025
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
2024
2025
Net profit margin (of gross profit)
-334.5%
This company
2024
2025
Asset turnover (of gross profit)
0.01×
This company
2024
2025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-11-23 – 2024-12-31
View
PDF
More on Novo Nordisk Foundation Cellerator P/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
